Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene

Molecular Endocrinology

Volumn 14, Issue 9, 2000, Pages 1472-1482

  Wood, Teresa L ^a,b   Rogler, Leslie E ^a,c   Czick, Maureen E ^a   Schuller, Alwin G P ^a   Pintar, John E ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c Liver Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4;

ALLELE; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DISRUPTION; GENE TARGETING; HETEROZYGOSITY; HOMOZYGOSITY; LIVER; MOUSE; NONHUMAN; ORGAN SIZE; ORGAN WEIGHT; POSTNATAL GROWTH; PRENATAL GROWTH; PRIORITY JOURNAL; SOUTHERN BLOTTING; SPLEEN;

EID: 0033734689     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.9.0517     Document Type: Article

References (84)

1. The extracellular regulation of growth factor action
2. Bioavailability: Is this a key event in regulating the actions of peptide growth factors?
3. Corticotropin-releasing hormone-binding protein and its possible role in neuroendocrinological research
4. Corticotropin releasing factor (CRF) binding protein: A novel regulator of CRF and related peptides
5. Insulin-like growth factor binding proteins and their role in controlling IGF actions
6. Latent transforming growth factor-β: Structural features and mechanisms of activation
7. Follistatin and its role as an activin-binding protein
8. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of novel IGFBP-5 in rat and human
9. Role of insulin-like growth factor binding proteins in controlling IGF actions
10. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats
11. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates
12. Insulin-like growth factor binding proteins in the human circulation: A review
13. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I
14. Insulin-like growth factors and their binding proteins: Biological actions
15. Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5
16. Tissue-specific expression of the insulin-like growth factor binding protein (IGFBP) mRNAs in mouse and rat development
17. Gene expression of the six insulin-like growth factor binding proteins (IGFBPs) in the mouse conceptus during mid- and late gestation
18. cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins
19. Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development
20. IGF-binding protein mRNAs in the human fetus: Tissue and cellular distribution of developmental expression
21. Insulin-like growth factor binding protein gene expression in the pregnant rat uterus and placenta
22. Cellular distribution of insulin-like growth factor binding protein mRNAs and peptides during rat lung development
23. mRNA expression patterns of the IGF system during mouse limb bud development, determined by whole mount in situ hybridization
24. Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proteins-1 and -2
25. The insulin-like growth factor binding proteins: Structure and biological functions
26. Insulin-like growth factor binding proteins
27. Hormonal and nutritional regulation of IGF-I and its binding proteins
28. Insulin-like growth factor carrier proteins in neonatal and adult rat serum are immunologically different: Demonstration using a new radioimmunoassay for the carrier protein from BRL-3A rat liver cells
29. Tissue, developmental, and metabolic regulation of messenger ribonucleic acid encoding a rat insulin-like growth factor-binding protein
30. Expression of insulin-like growth factor binding protein-1 and -2 genes through perinatal period in the rat
31. The expression pattern of an insulin-like growth factor (IGF)-binding protein gene is distinct from IGF-II in the midgestational rat embryo
32. Expression of the IGFBP-2 gene in post-implantation rat embryos
33. Insulin-like growth factor I and II and insulin-like growth factor binding protein-2 RNAs are expressed in adjacent tissues within rat embryonic and fetal limbs
34. Regulation of binding proteins for insulin-like growth factors in humans: Increased expression of IGF binding protein 2 during IGF-I treatment of healthy adults and in patients with extrahepatic tumour hypoglycaemia
35. A low molecular weight insulin-like growth factor binding protein from rat: cDNA cloning and tissue distribution of its messenger RNA
36. The fetal rat binding protein for insulin-like growth factors is expressed in the choroid plexus and cerebrospinal fluid of adult rats
37. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by gene targeting
38. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
39. Role of insulin-like growth factors in embryonic and postnatal growth
40. IGF-I is required for normal embryonic growth in mice
41. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal over-growth and perinatal lethality
42. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene
43. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons
44. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
45. Effects of an Igf1 gene null mutation on mouse reproduction
46. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus
47. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung
48. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development
49. MyoD or Myf-5 is required for the formation of skeletal muscle
50. ES-cells carrying two inactivated myf-5 alleles form skeletal muscle cells: Activation of an alternative muf-5-independent differentiation pathway
51. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin
52. Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants
53. Developmental roles of the retinoic acid receptors
54. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants
55. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice
56. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle during granulocyte differentiation
57. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death
58. Growth allometry of organs in giant transgenic mice
59. Growth enhancement of transgenic mice expressing human insulin-like growth factor I
60. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice
61. Expression of insulin-like growth factor-I in transgenic mice
62. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: Endocrine changes and effects on body and organ growth
63. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
64. Strain-dependent epithelial defects in mice lacking the EGF receptor
65. A defect of the splanchnic mesoderm caused by the mutant gene dominant hemimelia in the mouse
66. Hox11 controls the genesis of the spleen
67. The Hox11 gene is essential for cell survival during spleen development
68. Stress-induced effects on cell-mediated innate and adaptive memory components of the murine immune response to herpes simplex virus infection
69. Cyclic adenosine monophosphate stimulates insulin-like growth factor binding protein-4 and its messenger ribonucleic acid in a clonal endothelial cell line
70. Characterization of rat serum insulin-like growth factor-binding proteins by two-dimensional gel electrophoresis: Identification of a potentially novel form
71. Role of GH and IGF-I in the regulation of IGF-I, IGF-I receptor and IGF binding protein gene expression in the rat spleen
72. Growth allometry of organs, muscles and bones in mice from lines divergently selected on the basis of plasma insulin-like growth factor-I
73. Evidence for suppression of immune function by insulin-like growth factor-1 in dwarf rats in vivo
74. Systemic infusion of IGF-I or LR(3)IGF-I stimulates visceral organ growth and proliferation of gut tissues in suckling rats
75. The IGF-I axis in kidney and skeletal muscle of potassium deficient rats
76. Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth and sexual function. Evidence that such treatment does not affect sexual maturation of fertility
77. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys
78. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix
79. The MyoD family and myogenesis: Redundancy, networks, and thresholds
80. Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors
81. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
82. The nucleotide sequence of the rat cytoplasmic β-actin gene
83. Hormonal regulation of rat hypothalamic neuropeptide mRNAs: Effect of hypophysectomy and hormone replacement on growth-hormone-releasing factor, somatostatin and the insulin-like growth factors
84. Development of specific antibodies to rat insulin-like growth factor-binding proteins (IGFBP-2 to -6): Analysis of IGFBP production by rat granulosa cells